Labetalol Hydrochloride

盐酸拉贝洛尔

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameLabetalol Hydrochloride
Drug Alias Namelabetalol柳安羟胺Labetalolum盐酸柳胺苄心定盐酸柳胺羟胺 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors antagonists
TargetsAdrenergic receptors
Therapy Area/IndicationsCocaine-Related DisordersHypotensionHypertension +[4] 
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1984/08/01
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Disainuo Pharmaceutical Co Ltd
Inactive CompaniesCairo UniversityUniversity Of AlbertaNational Institute On Drug Abuse +[4] 
Active IndicationsHypertension
Inactive IndicationsCocaine-Related DisordersHypotensionStroke

Other Information

ATC CodeC07AG01
Related LinksWikipediaDrugBankKEGG